Cytek Biosciences (CTKB) Other Non Operating Income (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Other Non Operating Income data on file, last reported at $565000.0 in Q1 2026.

• Quarterly Other Non Operating Income fell 83.82% year-over-year to $565000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 million (down 17.64% YoY) and the FY2025 annual result came in at $8.8 million, up 97.2% from the prior year.
• Other Non Operating Income rose to $565000.0 in Q1 2026, from $258000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $3.7 million in Q2 2025 to a low of -$445000.0 in Q3 2022.
• A 5-year average of $1.3 million and a median of $1.2 million in 2023 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 111.67% — and 2025, when it jumped 6184.75%.
• Tracing CTKB's Other Non Operating Income over 5 years: stood at $2.1 million in 2022, then soared by 52.75% to $3.2 million in 2023, then sank by 84.63% to $491000.0 in 2024, then tumbled by 47.45% to $258000.0 in 2025, then soared by 118.99% to $565000.0 in 2026.
• The last three Other Non Operating Income figures came in at $565000.0 (Q1 2026), $258000.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.